Eye
Merck acquires EyeBio
Merck has announced the acquisition of all outstanding shares of EyeBio, making it a wholly-owned subsidiary, according to a company press release.
Better designed clinical research needed on lipid-based eye drops for DED
Lipid-based eye drops may help treat evaporative dry eye disease, although additional research, particularly with placebo-controlled study designs, is needed, according to a review.
OK-101 improves conjunctival staining, ocular pain in phase 2 trial of dry eye disease
Okyo Pharma released new data from its phase 2 trial of OK-101, a lipid conjugated chemerin peptide agonist, which showed a 68% improvement in both conjunctival staining and ocular pain among patients with dry eye disease.
Lumify increases short-term tear breakup time in patients with, without dry eye
NASHVILLE, Tenn. — Short-term noninvasive tear breakup time increased with use of Lumify eye drops in cohort of patients with and without dry eye disease, according to a poster presented at Optometry’s Meeting.
Licaminlimab has positive effect on dry eye signs in phase 2b trial
Improvements in multiple sign efficacy endpoints were reported for licaminlimab in patients with dry eye disease, with more pronounced effects in patients with a TNFR1 genetic biomarker, according to an Oculis press release.
Individual meibomian gland metrics may structurally change over short periods of time
Some individual meibomian gland metrics may structurally change over a period of hours or days, according to research published in Ophthalmic and Physiological Optics.
Bausch + Lomb launches Zenlens Echo custom scleral contact lenses in US
Bausch + Lomb announced the U.S. launch of Zenlens Echo, a non-prosthetic custom scleral contact lens technology designed for a range of fit needs, including patients with advanced ocular conditions such as corneal degeneration.
New Eye Health MicroGel supplement targets visual acuity, retinal health
Wellness company HealthyCell has announced the launch of Eye Health, the newest supplement in the company’s MicroGel product line, which is designed to promote visual acuity, protect against oxidative stress and support retinal health.
MiDROPS demonstrates safety, efficacy in phase 2 clinical trial
EyeCRO announced that its Microemulsion Drug Ocular Penetration System, or MiDROPS, demonstrated safety and efficacy in its first clinical application as a topical eye drop vehicle for dry eye disease.
Pegcetacoplan associated with reduced growth rates of geographic atrophy biomarkers
Intravitreal pegcetacoplan was associated with delayed atrophy of retinal pigment epithelium and photoreceptors among patients with geographic atrophy secondary to age-related macular degeneration, according to research.